Charles Ross Carter
CIK 1779359 · Chief Financial Officer · last filed 2024-07-01
Charles Ross Carter is a Chief Financial Officer who has filed 8 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for PBAXW, was dated Jul 1, 2024. Across all open-market trades the lifetime net is +$49.4K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
8
$49.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Chief Financial Officer | — | $0.05 | — | $0 | 2 | 2024-07-01 |
| ICAD INC (ICAD) Delisted | CHIEF FINANCIAL OFFICER | 7,000 | $3.87 | $27.1K | $49.4K | 4 | 2022-01-18 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-07-01 | CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-27 | CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-18 | ICAD INC (ICAD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-12 | ICAD INC (ICAD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-15 | ICAD INC (ICAD) Delisted | Buy (P) | +7,000 | $49.4K | EDGAR |
| 2021-08-04 | ICAD INC (ICAD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-11 | — | Disp (D) | — | $0 | |
| 2019-09-23 | — | Grant (A) | — | $0 |